Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective open-label investigation of non-surgical treatment with Xiapex
2010-019888-10Phase 4Completed
- Sponsor
- Pfizer
- Start
- Aug 2010
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Pfizer. Primary endpoint: Safety. Started Aug 2010; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on 2010-019888-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019888-10.